MarsBars/E+ through Getty Images FibroGen (NASDAQ:FGEN) mentioned late Friday that its chief monetary officer and chief medical officer will each be leaving the company due to…
Month: September 2024
Piper Sandler ups Intra-Cellular to obese, cites Caplyta potential Source: Seekingalpha
QuidelOrtho rises as Craig-Hallum upgrades on earnings power Source: Seekingalpha
Abbott launches over-the-counter glucose monitor, Lingo Source: Seekingalpha
McKesson slips as Q2 outlook underwhelms Source: Seekingalpha
Perspective gets FDA fast track status for radiopharmaceutical VMT01 Source: Seekingalpha
Cigna to offer biosimilar to J&J’s arthritis drug Stelara at $0 out-of-pocket Source: Seekingalpha
Eli Lilly bets $409M for AI-focused drug discovery Source: Seekingalpha
Lisata jumps on FDA orphan drug status for liver cancer drug Source: Seekingalpha
Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: Seekingalpha